ATC Group: J01CR04 Sultamicillin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01CR04 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01C Beta-lactam antibacterials, penicillins
4 J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
5 J01CR04 Sultamicillin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 1.5 g

Active ingredients in J01CR04

Active Ingredient Description
Sultamicillin

Sultamicillin is the tosylate salt of the double ester of sulbactam plus ampicillin. Sulbactam is a semisynthetic beta-lactamase inhibitor which, in combination with ampicillin, extends the antibacterial activity of the latter to include some beta-lactamase-producing strains of bacteria that would otherwise be resistant.

Related product monographs

Title Information Source Document Type  
UNASYN Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

Medicines in this ATC group

United States (US)

Austria (AT)

Cyprus (CY)

Estonia (EE)

Hong Kong (HK)

Japan (JP)

Lithuania (LT)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.